Epigral Limited (EPIGRAL.BO) Stock Overview
Explore Epigral Limited’s financial performance, market position, analyst ratings, and future outlook.
Epigral Limited (EPIGRAL.BO)
Key Financials
Key Financials
Market Cap
52B
P/E Ratio
19.15
EPS (TTM)
$63.09
ROE
0.13%
EPIGRAL.BO Stock Analysis & Investment Overview (BSE)
Our AI-powered analysis of Epigral Limited (BSE: EPIGRAL.BO) gives investors deep insight into how the stock performs on the BSE exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, Epigral Limited's BSE-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of EPIGRAL.BO on the BSE shows an RSI of 64.94, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $1719.59 for the BSE listing.
Key metrics behind Epigral Limited's BSE-traded stock include a P/E ratio of 19.15 and a market capitalization of 52B. Combined with our AI analysis, these give both institutional and retail investors a clear view of EPIGRAL.BO on the BSE.